Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predicting survival in people with manifest tetanus using three severity scores.

Official title: Comparison of Three Scoring Systems for Prediction of Mortality in Patients Admitted to the Intensive Care Unit With Manifest Tetanus

Run by Ain Shams University · NCT07512167 · Data updated 2026-11-12

This project will test whether three scoring systems (Tetanus Severity Score, Dakar Score, and Philips Score) can help predict which adults with manifest tetanus will survive their hospital stay.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment115 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo, Cairo Governorate)
StatusRecruiting
StartedApril 15, 2026
Main results expectedOctober 15, 2026
Study endsNovember 15, 2026
Registry record updatedSeptember 29, 2026
Trial IDNCT07512167 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age 18+) admitted to the ICU with manifest tetanus meeting WHO criteria are the ideal candidates for this project.

Probably not a fit

People under 18, those without manifest tetanus per WHO criteria, or patients with incomplete medical records or missing score data are excluded and unlikely to benefit from the results.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this observational cohort at Ain Shams University Hospitals and Demanhour Fever Hospital, adults admitted to the ICU with manifest tetanus will have three severity scores recorded on admission: the Tetanus Severity Score (TSS), Dakar Score, and Philips Score. Researchers will compare each score to the primary outcome of in-hospital mortality versus survival to hospital discharge. Patients younger than 18, those who do not meet WHO criteria for manifest tetanus, or cases with incomplete records for scores or outcomes will be excluded. The analysis will describe how well each score predicts mortality and may identify score thresholds linked to higher risk.

Why it matters

Potential benefit: If successful, these scoring systems could help clinicians identify high-risk tetanus patients early and guide treatment intensity and resource allocation.

How similar studies have gone: Similar scores such as the Dakar Score and earlier TSS evaluations have been used previously with mixed but generally promising results, though external validation in different centers remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Adults (age 18 years old or more).
* Any sex (male or female), regardless of gender identity.
* Diagnosis of manifest tetanus according to the WHO criteria (https://www.who.int/news-room/fact-sheets/detail/tetanus), that is the presence of one or both of the following criteria with or without the history of specific wound or injury:

  * Sustained spasm of the facial muscles in which person appears grinning.
  * Painful muscular contractions

Exclusion criteria:

* Age \< 18 years.
* Absent criteria of manifest tetanus, as per the WHO criteria (https://www.who.int/news-room/fact-sheets/detail/tetanus).
* Incomplete medical record with missing data required to calculate the Tetanus Severity Score, Philips Score, or Dakar score.
* Incomplete medical record with missing data regarding the primary outcome measure (survival to hospital discharge or in-hospital mortality).

Where it's running

  • Ain Shams University Hospitals & Demanhour Fever Hospital
    Cairo, Cairo Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.